Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Polyethylene Glycol 400, Propylene Glycol
Brand Name
Leader Preservative-free Ultra Lubricating Eye Drops
Generic Name
Polyethylene Glycol 400, Propylene Glycol
Active Ingredient
Polyethylene Glycol 400Category
Plasma Volume Expander [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .4 g/100mL | SOLUTION/ DROPS | OPHTHALMIC | 70000-0501 |
Detailed information about Leader Preservative-free Ultra Lubricating Eye Drops
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Leader Preservative-free Ultra Lubricating Eye Drops, you must consult a qualified healthcare professional.
Polyethylene Glycol 400 is a versatile polyether compound used primarily as an ophthalmic lubricant, a plasma volume expander, and a pharmaceutical solvent. It belongs to the class of osmotic agents and is widely utilized in treating dry eye syndrome and as a vehicle for various medications.
The dosage of Polyethylene Glycol 400 varies significantly based on the condition being treated and the formulation used.
For the relief of dry eye symptoms, the standard dosage is 1 to 2 drops in the affected eye(s) as needed. Many patients find relief with 3 to 4 applications daily, though it can be used more frequently if the formulation is preservative-free. If you are using PEG 400 for chronic dry eye, your ophthalmologist may recommend a specific schedule to maintain the integrity of the tear film.
When PEG 400 is used as a solvent in oral medications, the dose is determined by the active ingredient (e.g., the amount of PEG 400 in a 200 mg ibuprofen liquid gel). There is no independent 'dosage' for PEG 400 in these cases, but the total daily intake of PEG 400 should generally not exceed 10 mg/kg of body weight to avoid potential osmotic effects in the gut.
Polyethylene Glycol 400 is generally considered safe for pediatric use when applied topically as an eye drop. For children under the age of 6, it is recommended to consult a pediatrician before use to ensure the symptoms are not related to an underlying infection or injury. Systemic use of PEG 400 in children is typically limited to its role as an excipient in FDA-approved pediatric medications. Specific weight-based dosing for 'Calculi Dissolution' or 'Plasma Volume Expansion' in children must be strictly managed by a specialist in a hospital setting.
Because PEG 400 is primarily eliminated by the kidneys, patients with severe renal impairment (CrCl < 30 mL/min) should be monitored if receiving high doses of systemic PEG 400 (such as in certain IV drug formulations). Accumulation of PEG can lead to increased serum osmolality and potential metabolic complications.
No dosage adjustments are typically required for patients with hepatic impairment, as the liver plays a minimal role in the clearance of Polyethylene Glycol 400.
Older adults are more prone to dry eye syndrome and may use PEG 400 frequently. While no specific dose adjustment is needed, elderly patients should be cautioned about the risk of blurred vision immediately after application, which may increase the risk of falls.
Store Polyethylene Glycol 400 products at room temperature, typically between 15°C and 30°C (59°F to 86°F). Keep the container tightly closed when not in use. Protect from excessive heat and direct light.
If you are using PEG 400 on a schedule and miss a dose, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up.
An overdose of ophthalmic Polyethylene Glycol 400 is unlikely to cause serious systemic effects. However, excessive use may cause temporary irritation or blurred vision. If the solution is accidentally swallowed, especially by a child, contact a Poison Control Center immediately. Symptoms of oral overdose may include diarrhea, abdominal cramping, and dehydration due to the osmotic effect of the polymer in the intestines.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Polyethylene Glycol 400 is generally well-tolerated, especially in topical ophthalmic forms. However, the most common side effects include:
While extremely rare, serious reactions can occur.
> Warning: Stop taking Polyethylene Glycol 400 and call your doctor immediately if you experience any of these:
Long-term use of Polyethylene Glycol 400 in the eyes is generally considered safe. However, if the formulation contains preservatives (such as Benzalkonium Chloride), chronic use (more than 4-6 times daily) may lead to 'medicamentosa,' a condition where the preservatives themselves cause damage to the corneal epithelium. In such cases, switching to a preservative-free formulation is necessary. There is no evidence that long-term use of PEG 400 leads to systemic accumulation in healthy individuals.
No FDA black box warnings currently exist for Polyethylene Glycol 400. It is regarded as one of the safest polymers used in medical practice. However, healthcare providers caution against its use in patients with known hypersensitivity to any polyethylene glycol derivative.
Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
Polyethylene Glycol 400 is a highly stable and safe compound, but its use requires adherence to specific safety protocols to prevent complications. The most critical safety concern with ophthalmic use is the risk of secondary infection. If the tip of the dispensing bottle touches any surface, including the eye itself, it can become contaminated with bacteria or fungi, leading to serious ocular infections such as bacterial keratitis.
No FDA black box warnings for Polyethylene Glycol 400. It has a long-standing safety record when used according to label instructions.
While PEG 400 is often used as a 'hypoallergenic' vehicle, a small subset of the population has developed anti-PEG antibodies. This can lead to hypersensitivity reactions ranging from mild urticaria (hives) to life-threatening anaphylaxis. Patients who have had reactions to other PEG-containing products (like certain mRNA vaccines or bowel prep kits) should use PEG 400 with caution.
In clinical scenarios where PEG 400 is applied to large areas of denuded skin (such as in severe burn patients), there is a risk of systemic absorption. Historical data has shown that excessive absorption of low-molecular-weight PEGs can lead to renal tubular necrosis. Healthcare providers should monitor kidney function in patients with compromised skin integrity receiving PEG-based topicals.
Patients should not use Polyethylene Glycol 400 as a substitute for professional medical care. If eye pain, changes in vision, or persistent redness occurs, the patient must be evaluated for more serious conditions like glaucoma, uveitis, or corneal abrasions.
For standard OTC ophthalmic use, no routine laboratory monitoring is required. However, for specialized uses:
Polyethylene Glycol 400 eye drops can cause temporary blurring of vision. Patients should wait until their vision is completely clear before driving a motor vehicle or operating heavy machinery. This typically takes only a few minutes but is a critical safety consideration.
There are no known direct interactions between alcohol consumption and topical Polyethylene Glycol 400. However, alcohol can exacerbate systemic dehydration and dry eye symptoms, potentially reducing the perceived efficacy of the lubricant.
There is no withdrawal syndrome associated with Polyethylene Glycol 400. Patients can stop using the product at any time. However, the symptoms of dry eye or irritation are likely to return once the lubricating film is no longer being replenished.
> Important: Discuss all your medical conditions with your healthcare provider before starting Polyethylene Glycol 400.
There are no absolute contraindications for the use of Polyethylene Glycol 400 with other drugs. However, it should not be mixed directly in the same container with other medications unless specifically directed by a pharmacist, as it may alter the chemical stability of the other drug.
When used with other medicated eye drops (such as those for glaucoma or infections), PEG 400 can potentially alter the penetration of the active drug. The viscous film created by PEG 400 may act as a barrier, reducing the absorption of the second medication.
If PEG 400 is being absorbed systemically (e.g., through damaged skin), using it alongside other nephrotoxic drugs (like aminoglycoside antibiotics or NSAIDs) may theoretically increase the risk of kidney strain.
PEG 400 is often formulated with preservatives. In some cases, the polymer can form complexes with these preservatives, slightly altering their antimicrobial efficacy or increasing their retention time on the ocular surface.
There are no documented interactions between Polyethylene Glycol 400 and specific foods. Unlike some medications, its absorption (when used as an oral excipient) is not significantly affected by dairy or high-fat meals.
No significant interactions have been identified with common herbal supplements like St. John's Wort or Ginkgo Biloba. However, supplements that have a diuretic effect (like dandelion root) may worsen the underlying dry eye condition that PEG 400 is intended to treat.
Polyethylene Glycol 400 can interfere with certain laboratory tests if present in high concentrations in the blood:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Polyethylene Glycol 400 must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to PEG 400 may also react to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Polyethylene Glycol 400.
Polyethylene Glycol 400 is generally classified as Pregnancy Category C (or equivalent under newer labeling systems). This means that while there are no adequate, well-controlled studies in pregnant women, animal studies have not shown significant teratogenic effects at standard doses. Because systemic absorption from the eye is negligible, the risk to the fetus is considered extremely low. However, it should only be used during pregnancy if clearly needed and after discussion with a healthcare provider. There is no evidence that PEG 400 affects fertility or causes trimester-specific risks.
It is not known whether Polyethylene Glycol 400 is excreted in human milk. However, given its high molecular weight (even at 400 Da) and minimal systemic absorption from topical routes, it is highly unlikely that clinically significant amounts would reach the nursing infant. The risk-benefit ratio usually favors the use of PEG 400 for maternal dry eye symptoms during lactation.
PEG 400 is widely used in pediatric populations, primarily in eye drops and as an excipient in liquid medications. It is generally considered safe for children. However, the 'Plasma Volume Expander' and 'Calculi Dissolution' uses are specialized and not standard for pediatric care outside of clinical trials or emergency hospital settings. Parents should ensure that children do not touch the dropper tip to prevent eye infections.
Elderly patients are the primary users of PEG 400 due to the high prevalence of age-related dry eye. While safe, clinicians should be aware of 'Polypharmacy concerns.' If an elderly patient is using multiple eye drops for glaucoma, the addition of PEG 400 must be timed correctly to avoid washing out the glaucoma medication. Additionally, reduced renal clearance in the elderly means that systemic exposure (if any) will last longer.
In patients with a GFR < 60 mL/min, caution is advised if PEG 400 is being used systemically or over large areas of broken skin. While no specific dose-adjustment table exists for PEG 400, monitoring for an increased osmolal gap is the standard clinical approach in high-exposure cases.
No adjustments are necessary for patients with liver disease. The pharmacokinetics of PEG 400 are independent of hepatic function.
> Important: Special populations require individualized medical assessment.
Polyethylene Glycol 400 is a non-ionic surfactant and polymer. Its primary clinical effect is derived from its hydrophilicity. Each molecule of PEG 400 contains multiple oxygen atoms that act as hydrogen bond acceptors, allowing it to bind and retain water. On the ocular surface, it integrates into the mucin layer of the tear film, enhancing the 'wetting' of the corneal epithelium. This reduces surface tension and provides a viscoelastic shield. In its role as a Calculi Dissolution Agent [EPC], it acts as a solvent that can disrupt the ionic bonds in calcium-based stones through weak chelation and pH modification.
The onset of action for Polyethylene Glycol 400 eye drops is nearly immediate, providing relief within seconds of application. The duration of effect is typically 2 to 4 hours, depending on the severity of the dry eye and the rate of tear turnover. It does not target specific receptors (like G-protein coupled receptors) but rather acts through physical and osmotic properties. No tolerance development has been reported; the drug remains effective with repeated use.
| Parameter | Value |
|---|---|
| Bioavailability | <1% (Topical); ~60% (Oral) |
| Protein Binding | 0% |
| Half-life | 2 - 4 hours (Systemic) |
| Tmax | 1 - 2 hours (Oral) |
| Metabolism | Minimal (Alcohol Dehydrogenase) |
| Excretion | Renal 80-90% (Unchanged) |
Polyethylene Glycol 400 is classified as an Ophthalmic Lubricant and an Osmotic Agent. Within the EPC framework, it is recognized as a Plasma Volume Expander, a Non-Standardized Chemical Allergen, and a Calculi Dissolution Agent. It is chemically related to other PEGs like PEG 3350 (MiraLAX) and PEG 4000, though its lower molecular weight gives it unique permeability and viscosity characteristics.
Common questions about Leader Preservative-free Ultra Lubricating Eye Drops
Polyethylene Glycol 400 is primarily used as a lubricant in eye drops to treat dry, irritated, or burning eyes. It works by binding to water and creating a protective film over the ocular surface to prevent moisture loss. Beyond eye care, it is used as a solvent in many liquid-filled capsules and topical creams to help dissolve other medications. In specialized medical settings, it may also be used in solutions to help dissolve kidney stones or as a plasma volume expander to support blood pressure. It is a versatile compound found in both over-the-counter and prescription products.
The most common side effects are localized to the eye and include temporary blurred vision immediately after the drops are applied. Some users may also experience a mild stinging or burning sensation that usually lasts only a few seconds. You might also notice a slight clear discharge or crusting on the eyelashes after the drops dry. These effects are generally mild and do not require medical treatment. If these symptoms persist or worsen, you should consult your healthcare provider to ensure there isn't a more serious underlying issue.
There are no known direct drug-drug interactions between Polyethylene Glycol 400 and alcohol. Since PEG 400 is mostly used topically in the eyes, very little of the medication enters your bloodstream. However, it is important to note that alcohol consumption can lead to systemic dehydration, which often makes dry eye symptoms worse. If you are using PEG 400 to treat chronic dry eye, limiting alcohol intake may help the medication work more effectively. Always discuss your lifestyle habits with your doctor when starting a new treatment.
Polyethylene Glycol 400 is generally considered safe to use during pregnancy, especially in the form of eye drops. Because the medication is applied topically and very little is absorbed into the systemic circulation, the risk to the developing fetus is extremely low. It is classified as Pregnancy Category C, meaning it should be used if the benefits outweigh the risks. Most doctors agree that treating maternal dry eye discomfort is important for the mother's well-being. However, you should always inform your obstetrician about all medications, including over-the-counter eye drops, that you are using during pregnancy.
Polyethylene Glycol 400 begins to work almost immediately upon contact with the eye. Most patients feel a soothing sensation and relief from dryness within seconds of instilling the drops. However, the initial blurred vision caused by the thickness of the liquid may take a minute or two to clear. While the immediate relief is fast, the effects typically wear off after 2 to 4 hours as the polymer is washed away by natural blinking and tear drainage. For chronic conditions, regular use as directed by a doctor is necessary to maintain comfort.
Yes, you can stop using Polyethylene Glycol 400 at any time without experiencing withdrawal symptoms. It is not a habit-forming medication and does not affect the body's natural processes in a way that requires a tapering period. However, if you are using it to manage a chronic condition like dry eye syndrome, your symptoms (such as burning, redness, and irritation) will likely return shortly after you stop. If you find that you need to use the drops more than six times a day, you should see an eye doctor for a more permanent treatment plan.
If you miss a dose of Polyethylene Glycol 400, simply apply the drops as soon as you remember. If it is almost time for your next scheduled application, skip the missed dose and continue with your regular routine. Since this medication is often used on an 'as-needed' basis for symptom relief, missing a dose is generally not a cause for concern. You should never apply extra drops or 'double up' to make up for a missed dose, as this may cause temporary irritation or excessively blurred vision. Consistency is key for managing chronic dryness.
There is no evidence to suggest that Polyethylene Glycol 400 causes weight gain. When used as an eye drop or a topical cream, the amount of the compound that reaches the systemic circulation is negligible and has no effect on metabolism or appetite. Even when used as an excipient in oral medications, the quantities are too small to contribute significant calories or affect weight. If you experience sudden or unexplained weight gain while using any medication, you should consult your healthcare provider to investigate other potential causes, such as fluid retention or unrelated medical conditions.
Polyethylene Glycol 400 can generally be used alongside other medications, but timing is important for eye drops. If you are using other ophthalmic products, such as antibiotic drops or glaucoma medication, you should wait at least 10 minutes between applications. This prevents the PEG 400 from washing out the other medication or interfering with its absorption. If you are taking oral medications that contain PEG 400 as an inactive ingredient, there are rarely any significant interactions. Always provide your doctor with a full list of your medications to ensure safety.
Yes, Polyethylene Glycol 400 is widely available as a generic product and is a common ingredient in many store-brand artificial tears. It is often sold under various brand names like Systane or as 'Lubricant Eye Drops' in generic packaging. Generic versions are required by the FDA to have the same quality and efficacy as the brand-name versions. Because it is an over-the-counter product, you can often find it at a lower cost by choosing the generic or store-brand option. Always check the active ingredient list on the label to ensure it contains Polyethylene Glycol 400.
Other drugs with the same active ingredient (Polyethylene Glycol 400)